Cirrhosis clinical trials in Texas
13 studies for Cirrhosis are looking for participants at sites in Texas.
Cities in Texas
LIVERAGEâ„¢: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Texas Clinical Research Institute, LLC, Arlington
- IMA Clinical Research Austin, Austin
- American Research Corporation - Austin, Austin
- and 35 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Texas Clinical Research Institute, LLC, Arlington
- Epic Medical Research - Carrollton, Carrollton
- The Liver Institute at Methodist Dallas, Dallas
- and 5 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 30, 2026 · NCT07325526National Liver Cancer Screening Trial
- UT Southwestern Medical Center and Parkland Hospital, Dallas
- Baylor College of Medicine, Houston
RecruitingPhase 4
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
- Research Site, Austin
- Research Site, Denison
- Research Site, Georgetown
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07610837Multi-analyte Blood Test Clinical Trial
- South Texas Research Institute, Edinburg
- Texas Gastro Research, El Paso
- Impact Research Institute, Waco
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05199259Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05181826High Dose Albumin in Refractory Ascites
- Baylor St' Lukes Medical center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT05867602Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
- UT Health San Antonio, San Antonio
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 6, 2026 · NCT06526104Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Baylor College of Medicine (Scott & White), Dallas
- Michael E DeBakey VA Medical Center, Houston
- Baylor St. Luke's Medical Centre, Houston
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Oct 20, 2025 · NCT04613921Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
- University of Texas Southwestern Medical Center, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2025 · NCT05028829Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
- Methodist Health System, Dallas Medical Center, Dallas
- VA North Texas Healthcare System, Dallas
- Texas Liver Institute, San Antonio
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 5, 2025 · NCT05490888EGCG for Hepatocellular Carcinoma Chemoprevention
- UT Southwestern, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 5, 2025 · NCT06015022Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- First Surgical Hospital, Bellaire
- Endeavor Clinical Trials, San Antonio
RecruitingObservational study
Ages 18 to 75 · All sexes · Updated Aug 14, 2025 · NCT07122700From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.